The Artificial Intelligence Virtual Cell (AIVC) is an advanced computational tool that combines detailed cellular data from single-cell and spatial technologies, including gene expression, epigenetic changes, and cell characteristics, while incorporating fundamental physical and biological rules. This approach creates accurate digital twins of cells that can simulate how tumors develop, evolve, and change over time across multiple scales, from molecules to tissues. Unlike traditional models based on fixed equations that struggle with cancer's extreme complexity and diversity, AIVC learns patterns directly from large biological datasets using modern AI methods. It models cells as intelligent agents operating in a mathematical space and refines predictions through ongoing feedback. This enables patient-specific computer simulations of drug effects, genetic alterations, and tumor environment interactions, moving precision oncology toward truly personalized and dynamic treatment strategies. Despite challenges like incomplete datasets, validation needs, and high computing demands, AIVC is maturing into a valuable research partner and advancing toward clinical use, positioned to transform cancer care.
Loew L.M. and Schaff J.C. (2001). The virtual cell: A software environment for computational cell biology. Trends Biotechnol.19:401−406. DOI:10.1016/S0167-7799(01)01740-1
Yang T., Wang Y.-Y., Ma F., et al. (2025). Build the virtual cell with artificial intelligence: A perspective for cancer research. Mil. Med. Res.12:4. DOI:10.1186/s40779-025-00591-6
Hao M., Gong J., Zeng X., et al. (2024). Large-scale foundation model on single-cell transcriptomics. Nat. Methods21:1481−1491. DOI:10.1038/s41592-024-02305-7
Bunne C., Roohani Y., Rosen Y., et al. (2024). How to build the virtual cell with artificial intelligence: Priorities and opportunities. Cell187:7045−7063. DOI:10.1016/j.cell.2024.11.015
Qian L., Dong Z. and Guo T. (2025). Grow AI virtual cells: Three data pillars and closed-loop learning. Cell Res.35:319−321. DOI:10.1038/s41422-025-01101-y
Wang Q., Pan Y., Zhou M., et al. (2025). scDrugMap: Benchmarking large foundation models for drug response prediction. Nat. Commun.17:730. DOI:10.1038/s41467-025-67481-2
Johnson J.A.I., Bergman D.R., Rocha H.L., et al. (2025). Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories. Cell188:4711−4733. DOI:10.1016/j.cell.2025.06.048
Adduri A.K., Gautam D., Bevilacqua B., et al. (2025). Predicting cellular responses to perturbation across diverse contexts with State. Preprint at bioRxiv. DOI:10.1101/2025.06.26.661135
Luciani F., Safavi A., Guruprasad P., et al. (2025). Advancing CAR T-cell therapies with artificial intelligence: Opportunities and challenges. Blood Cancer Discov.6:159−162. DOI:10.1158/2643-3230.BCD-23-0240
Wei R., Wang B., Yan B., et al. (2026). From equations to agents: The artificial intelligence virtual cell reshaping precision oncology. The Innovation Oncology 1:100002. https://doi.org/10.59717/j.xinn-oncol.2026.100002
Wei R., Wang B., Yan B., et al. (2026). From equations to agents: The artificial intelligence virtual cell reshaping precision oncology. The Innovation Oncology1:100002. https://doi.org/10.59717/j.xinn-oncol.2026.100002
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Share the QR code with wechat scanning code to friends and circle of friends.
Article Metrics
Article views(5876)PDF downloads(2060)
Relative Articles
Cited by
Catalog
Export File
Citation
Wei R., Wang B., Yan B., et al. (2026). From equations to agents: The artificial intelligence virtual cell reshaping precision oncology. The Innovation Oncology 1:100002. https://doi.org/10.59717/j.xinn-oncol.2026.100002
Wei R., Wang B., Yan B., et al. (2026). From equations to agents: The artificial intelligence virtual cell reshaping precision oncology. The Innovation Oncology1:100002. https://doi.org/10.59717/j.xinn-oncol.2026.100002